Journal of Affective Disorders 1994: Vol 32 Index

10 Pages·1994·2.3 MB·English

LSEVIER
Journal of Affective Disorders 32 (1994) 289-291
Author Index
Abou-Saleh, M.T., see Wilkinson, A.M. (32) 163 DeRubeis, R.J., see Garvey, M.J. (32) 45
Alda, M., see Grof, P. (32) 85 D’Hondt, P., Maes, M., Leysen, J.E., Gommeren, W., Scharpé,
Anderson, D.N., see Wilkinson, A.M. (32) 163 S. and Cosyns, P.
Aoki, Y., Fujihara, S. and Kitamura, T. Binding of [*H]paroxetine to platelets of depressed pa-
Panic attacks and panic disorder in a Japanese non-patient tients: seasonal differences and effects of diagnostic classi-
population: epidemiology and psychosocial correlates (32) fication (32) 27
51 Dick, H., see Moffoot, A.P.R. (32) 257
Arat6, M., see Szadéczky, E. (32) 1 Donald, J., see Le, F. (32) 187
D’Souza, J., see Chouinard, G. (32) 105
Dybbro, J., see Licht, R.W. (32) 179
Bakish, D., see Chouinard, G. (32) 105
Bauer, M.S., Whybrow, P.C., Gyulai, L., Gonnel, J. and Yeh,
H.-S. Ebert, D. and Martus, P.
Testing definitions of dysphoric mania and hypomania: Somatization as a core symptom of melancholic type de-
prevalence, clinical characteristics and inter-episode stabil- pression. Evidence from a cross-cultural study (32) 253
ity (32) 201 Ebmeier, K.P., see Moffoot, A.P.R. (32) 257
Beauclair, L., see Chouinard, G. (32) 105
Belanger, M.C., see Chouinard, G. (32) 105 Fahndrich, E., see Ulrich, G. (32) 213
Bennie, J., see Moffoot, A.P.R. (32) 257 Farrar, G., see Wilkinson, A.M. (32) 163
Bergman, U., see Isacsson, G. (32) 277 Fawcett, J.P., see Menkes, D.B. (32) 37
Blackburn, I.-M., see Moore, R.G. (32) 239 Fazekas, I., see Szad6éczky, E. (32) 1
Blair, J.A., see Wilkinson, A.M. (32) 163 Fineberg, N.A., Cowen, P.J., Kirk, J.W. and Montgomery,
Bradwejn, J., see Chouinard, G. (32) 105 S.A.
Neuroendocrine responses to intravenous L-tryptophan in
obsessive compulsive disorder (32) 97
Campling, G.M., see Young, A.H. (32) 139
Franchini, L., Gasperini, M. and Smeraldi, E.
Carroll, S., see Moffoot, A.P.R. (32) 257
A 24-month follow-up study of unipolar subjects: a com-
Catalan, R., see Marcos, T. (32) 133
parison between lithium and fluvoxamine (32) 225
Chandrasekaran, R., see Mathew, M.R.K. (32) 157
Fujihara, S., see Aoki, Y. (32) 51
Checkley, S., see Lam, D.H. (32) 75
Chouinard, G., Saxena, B.M., Nair, N.P.V., Kutcher, S.P.,
Bakish, D., Bradwejn, J., Kennedy, S.H., Sharma, V., Gangadhar, B.N., see Hofmann, P. (32) 127
Remick, R.A., Kukha-Mohamad, S.A., Belanger, M.C., Garvey, M.J. and Schaffer, C.B.
Snaith, J., Beauclair, L., Pohlmann, H. and D’Souza, J. Are some symptoms of depression age dependent? (32)
A Canadian multicentre placebo-controlled study of a 247
fixed dose of brofaromine, a reversible selective MAO-A Garvey, M.J., Hollon, $.D. and DeRubeis, R.J.
inhibitor, in the treatment of major depression (32) 105 Do depressed patients with higher pretreatment stress
Christodoulou, G.N., see Lykouras, L. (32) 233 levels respond better to cognitive therapy than imipramine?
Coates, D.C., see Menkes, D.B. (32) 37 (32) 45
Cosyns, P., see D’Hondt, P. (32) 27 Gasperini, M., see Franchini, L. (32) 225
Cowen, P.J., see Fineberg, N.A. (32) 97 Gasto, C., see Marcos, T. (32) 133
Cowen, P.J., see Young, A.H. (32) 139 Gillberg, C., see Ivarsson, T. (32) 115
290 Author Index / Journal of Affective Disorders 32 (1994) 289-291
Glod, C., see Oren, D.A. (32) 197 Moclobemide and fluoxetine in atypical depression: a dou-
Gommeren, W., see D’Hondt, P. (32) 27 ble-blind trial (32) 169
Gonnel, J., see Bauer, M.S. (32) 201 Lund, H., see Licht, R.W. (32) 179
Goodwin, G.M., see Moffoot, A.P.R. (32) 257 Lykouras, L., Christodoulou, G.N., Malliaras, D. and Stefanis,
Gouliaev, G., see Licht, R.W. (32) 179 C.
Green, B., see Lam, D.H. (32) 75 The prognostic importance of delusions in depression: a
Grof, E., see Grof, P. (32) 85 6-year prospective follow-up study (32) 233
Grof, P., Alda, M., Grof, E., Zvolsky, P. and Walsh, M.
Lithium response and genetics of affective disorders (32) Maes, M., see D’Hondt, P. (32) 27
85 Malliaras, D., see Lykouras, L. (32) 233
Gutiérrez, F., see Marcos, T. (32) 133 Marcos, T., Salamero, M., Gutiérrez, F., Catalan, R., Gasto,
Gyulai, L., see Bauer, M.S. (32) 201 C. and Lazaro, L.
Cognitive dysfunctions in recovered melancholic patients
Hatzinger, R., see Hofmann, P. (32) 127 (32) 133
Haug, H.-J., see Ulrich, G. (32) 213 Martus, P., see Ebert, D. (32) 253
Healy, S., see Willner, P. (32) 13 Mathew, M.R.K., Chandrasekaran, R. and Sivakumar, V.
Hockney, R.A., see Young, A.H. (32) 139 A study of life events in mania (32) 157
Hofmann, P., Gangadhar, B.N., Probst, Ch., Koinig, G. and Menkes, D.B., Coates, D.C. and Fawcett, J.P.
Hatzinger, R. Acute tryptophan depletion aggravates premenstrual syn-
TSH response to TRH and ECT (32) 127 drome (32) 37
Hollon, $.D., see Garvey, M.J. (32) 45 Merinder, L., see Licht, R.W. (32) 179
Mitchell, P., see Le, F. (32) 187
Isacsson, G., Bergman, U. and Rich, C.L. Moffoot, A.P.R., O’Carroll, R.E., Bennie, J., Carroll, S., Dick,
Antidepressants, depression and suicide: an analysis of the H., Ebmeier, K.P. and Goodwin, G.M.
San Diego study (32) 277 Diurnal variation of mood and neuropsychological func-
Ito, Y.N., see Oren, D.A. (32) 197 tion in major depression with melancholia (32) 257
Montgomery, S.A., see Fineberg, N.A. (32) 97
Ivarsson, T., Lidberg, A. and Gillberg, C.
The Birleson Depression Self-Rating Scale (DSRS). Clini- Moore, R.G. and Blackburn, I.-M.
cal evaluation in an adolescent inpatient population (32) The relationship of sociotropy and autonomy to symptoms,
115 cognition and personality in depressed patients (32) 239
Joyce, P.R., see Sullivan, P.F. (32) 21 Nair, N.P.V., see Chouinard, G. (32) 105
O’Carroll, R.E., see Moffoot, A.P.R. (32) 257
Kaschka, W.P., see Rechlin, T. (32) 271
Kennedy, S.H., see Chouinard, G. (32) 105 Oren, D.A., Teicher, M.H., Schwartz, P.J., Glod, C., Turner,
E.H., Ito, Y.N., Sedway, J., Rosenthal, N.E. and Wehr,
Kirk, J.W., see Fineberg, N.A. (32) 97 -
T.A.
Kitamura, T., see Aoki, Y. (32) 51
A controlled trial of cyanocobalamin (Vitamin B,,) in the
Kiviruusu, O., see Lonnqvist, J. (32) 169
treatment of winter seasonal affective disorder (32) 197
Koinig, G., see Hofmann, P. (32) 127
Kukha-Mohamad, S.A., see Chouinard, G. (32) 105
Kutcher, S.P., see Chouinard, G. (32) 105 Pohlmann, H., see Chouinard, G. (32) 105
Possl, J., see Von Zerssen, D. (32) 61
Power, M.J., see Lam, D.H. (32) 75
Lam, D.H., Green, B., Power, M.J. and Checkley, S.
Probst, Ch., see Hofmann, P. (32) 127
The impact of social cognitive variables on the initial level
of depression and recovery (32) 75
Lazaro, L., see Marcos, T. (32) 133 Rapaport, M.H.
Le, F., Mitchell, P., Vivero, C., Waters, B., Donald, J., Selbie, Immune parameters in euthymic bipolar patients and nor-
L.A., Shine, J. and Schofield, P. mal volunteers (32) 149
Exclusion of close linkage of bipolar disorder to the G,-a Rechlin, T., Weis, M., Spitzer, A. and Kaschka, W.P.
subunit gene in nine Australian pedigrees (32) 187 Are affective disorders associated with alterations of heart
Leeming, R.J., see Wilkinson, A.M. (32) 163 rate variability? (32) 271
Leysen, J.E., see D'Hondt, P. (32) 27 Remick, R.A., see Chouinard, G. (32) 105
Licht, R.W., Gouliaev, G., Vestergaard, P., Dybbro, J., Lund, Rich, C.L., see Isacsson, G. (32) 277
H. and Merinder, L. Rihmer, Z., see Szaddéczky, E. (32) 1
Treatment of manic episodes in Scandinavia: the use of Rosenthal, N.E., see Oren, D.A. (32) 197
neuroleptic drugs in a clinical routine setting (32) 179
Lidberg, A., see Ivarsson, T. (32) 115 Salamero, M., see Marcos, T. (32) 133
Lonnqvist, J., Sihvo, S., Syvalahti, E. and Kiviruusu, O. Saxena, B.M., see Chouinard, G. (32) 105
Author Index / Journal of Affective Disorders 32 (1994) 289-291 291
Schaffer, C.B., see Garvey, M.J. (32) 247 clomipramine-treated depressive inpatients and the pre-
Scharpé, S., see D’Hondt, P. (32) 27 diction of therapeutic outcome (32) 213
Schofield, P., see Le, F. (32) 187
Schrader, G. Vestergaard, P., see Licht, R.W. (32) 179
Natural history of chronic depression: predictors of change Vivero, C., see Le, F. (32) 187
in severity over time (32) 219 Von Zerssen, D., Tauscher, R. and Possl, J.
Schwartz, P.J., see Oren, D.A. (32) 197 The relationship of premorbid personality to subtypes of
Sedway, J., see Oren, D.A. (32) 197 an affective illness. A replication study by means of an
Selbie, L.A., see Le, F. (32) 187 operationalized procedure for the diagnosis of personality
Sharma, V., see Chouinard, G. (32) 105 structures (32) 61
Sharpley, A.L., see Young, A.H. (32) 139
Shine, J., see Le, F. (32) 187 Walsh, M., see Grof, P. (32) 85
Sihvo, S., see Lonnqvist, J. (32) 169 Waters, B., see Le, F. (32) 187
Sivakumar, V., see Mathew, M.R.K. (32) 157 Wehr, T.A., see Oren, D.A. (32) 197
Smeraldi, E., see Franchini, L. (32) 225 Weis, M., see Rechlin, T. (32) 271
Snaith, J., see Chouinard, G. (32) 105 Wesson, M., see Wilkinson, A.M. (32) 163
Spitzer, A., see Rechlin, T. (32) 271 Whybrow, P.C., see Bauer, M.S. (32) 201
Stefanis, C., see Lykouras, L. (32) 233 Wilkinson, A.M., Anderson, D.N., Abou-Saleh, M.T., Wes-
Sullivan, P.F. and Joyce, P.R. son, M., Blair, J.A., Farrar, G. and Leeming, R.J.
Effects of exclusion criteria in depression treatment stud- 5-Methyltetrahydrofolate level in the serum of depressed
ies (32) 21 subjects and its relationship to the outcome of ECT (32)
Syvalahti, E., see Lonnqvist, J. (32) 169 163
Szadéczky, E., Fazekas, I., Rihmer, Z. and Araté, M. Willner, P. and Healy, S.
The role of psychosocial and biological variables in sepa- Decreased hedonic responsiveness during a brief depres-
rating chronic and non-chronic major depression and sive mood swing (32) 13
early-late-onset dysthymia (32) 1
Yeh, H.-S., see Bauer, M.S. (32) 201
Tauscher, R., see Von Zerssen, D. (32) 61 Young, A.H., Sharpley, A.L., Campling, G.M., Hockney, R.A.
Teicher, M.H., see Oren, D.A. (32) 197 and Cowen, P.J.
Turner, E.H., see Oren, D.A. (32) 197 Effects of hydrocortisone on brain 5-HT function and
sleep (32) 139
Ulrich, G., Haug, H.-J. and Fahndrich, E.
Acute vs. chronic EEG effects in maprotiline- and in Zvolsky, P., see Grof, P. (32) 85

journal of
AFFECTIVE
DISORDERS
ae
Journal of Affective Disorders 32 (1994) 293~—297
Keyword Index
Acute vs. chronic effects Atypical depression
Antidepressive drug; EEG vigilance; Test-dose model (Ulrich, Moclobemide; Fluoxetine (Lonnqvist, J. (32) 169)
G. (32) 213)
Autoantibody
Adolescence Bipolar disorder; Immunology; Flow cytometry; STL-2R; IL-2
Depression; Childhood; Self rating scale (Ivarsson, T. (32) (Rapaport, M.H. (32) 149)
115)
Autonomy
Affective disorder Sociotropy; Depression; Anxiety; Attitude; Vulnerability
Genetics; Lithium (Grof, P. (32) 85) (Moore, R.G. (32) 239)
Affective symptom Bipolar disorder
Depression; Age factor (Garvey, M.J. (32) 247) Immunology; Flow cytometry; SIL-2R; IL-2; Autoantibody
(Rapaport, M.H. (32) 149)
Age factor
Depression; Affective symptom (Garvey, M.J. (32) 247) G protein; Linkage analysis; G.-a; Chromosome 20 (Le, F.
(32) 187)
Anhedonia
Depression; Fawcett-Clark Pleasure Capacity Scale; Mood Depressive disorder; Mania; Assessment and diagnosis (Bauer,
induction; Cheese; Visual analogue scale (Willner, P. (32) 13) M.S. (32) 201)
Antidepressant Bipolar I / II disorder
Monoamine oxidase inhibitor; Selective serotonin reuptake Premorbid personality; Manic type; Melancholic type; Unipo-
inhibitor (Chouinard, G. (32) 105) lar depression; Mania (Von Zerssen, D. (32) 61)
Suicide; Depression; Toxicology (Isacsson, G. (32) 277) Borderline personality disorder
Depression; Treatment; Exclusion-criteria; Treatment of De-
Antidepressive drug pression Collaborative Research Program; Maintenance Ther-
Acute vs. chronic effects; EEG vigilance; Test-dose model apies for Recurrent Depression Protocol (Sullivan, P.F. (32)
(Ulrich, G. (32) 213) 21)
Anxiety Brofaromine
Sociotropy; Autonomy; Depression; Attitude; Vulnerability Major depression (Chouinard, G. (32) 105)
(Moore, R.G. (32) 239)
Buspirone
Assessment and diagnosis Hydrocortisone; 5-HT,, receptor; Hypothermia; REM sleep
Bipolar disorder; Depressive disorder; Mania (Bauer, M.S. (Young, A.H. (32) 139)
(32) 201)
Cheese
Attitude Depression; Anhedonia; Fawcett-Clark Pleasure Capacity
Sociotropy; Autonomy; Depression; Anxiety; Vulnerability Scale; Mood induction; Visual analogue scale (Willner, P. (32)
(Moore, R.G. (32) 239) 13)
294 Keyword Index / Journal of Affective Disorders 32 (1994) 293-297
Childhood Cyanocobalamin; Seasonal affective disorder (Oren, D.A. (32)
Depression; Adolescence; Self rating scale (Ivarsson, T. (32) 197)
115)
Delusion; Follow-up; Psychoprophylaxis (Lykouras, L. (32)
Chromosome 20 233)
Bipolar disorder; G protein; Linkage analysis; G,-a (Le, F.
(32) 187)
Sociotropy; Autonomy; Anxiety; Attitude; Vulnerability
(Moore, R.G. (32) 239)
Chronic depression
Outcome; Predictor (Schrader, G. (32) 219)
Age factor; Affective symptom (Garvey, M.J. (32) 247)
Cognition
Somatization; Cross-cultural; Turkish; Melancholia (Ebert, D.
Major depression; Diurnal rhythm; Cortisol (Moffoot, A.P.R.
(32) 253)
(32) 257)
Suicide; Antidepressant; Toxicology (Isacsson, G. (32) 277)
Cognitive therapy |
Stress; Imipramine; Mood disorder; Depression (Garvey, M.J.
(32) 45) Depressive disorder
Melancholia; Intellectual impairment; Neuropsychology
Cognitive variable (Marcos, T. (32) 133)
Depression (Lam, D.H. (32) 75)
Bipolar disorder; Mania; Assessment and diagnosis (Bauer,
Cortisol M.S. (32) 201)
Major depression; Cognition; Diurnal rhythm (Moffoot,
A.P.R. (32) 257) Diurnal rhythm
Major depression; Cognition; Cortisol (Moffoot, A.P.R. (32)
Cross-cultural 257)
Depression; Somatization; Turkish; Melancholia (Ebert, D.
(32) 253)
Dysthymia
Major depression; Long-term/short-term (Szadéczky, E. (32)
Cyanocobalamin 1)
Seasonal affective disorder; Depression (Oren, D.A. (32) 197)
Early mental trauma
Delusion
Panic disorder; Panic attack; Lifetime prevalence; Help-seek-
Depression; Follow-up; Psychoprophylaxis (Lykouras, L. (32)
ing behavior; Harsh discipline (Aoki, Y. (32) 51)
233)
ECT
Depression
Depression; Folate (Wilkinson, A.M. (32) 163)
Anhedonia; Fawcett-Clark Pleasure Capacity Scale; Mood
induction; Cheese; Visual analogue scale (Willner, P. (32) 13)
EEG vigilance
Acute vs. chronic effects; Antidepressive drug; Test-dose
Treatment; Exclusion-criteria; Borderline personality disor-
model (Ulrich, G. (32) 213)
der; Treatment of Depression Collaborative Research Pro-
gram; Maintenance Therapies for Recurrent Depression Pro-
tocol (Sullivan, P.F. (32) 21) Electroconvulsive therapy
Thyrotropin-releasing hormone; Major depression; Schizo-
Paroxetine; [*H]Paroxetine binding site; Platelets; Serotonin; phrenia; Hypothalamic-pituitary-thyroid-axis (Hofmann, P.
Seasonality (D’Hondt, P. (32) 27) (32) 127)
Stress; Cognitive therapy; Imipramine; Mood disorder Exclusion-criteria
(Garvey, M.J. (32) 45) Depression; Treatment; Borderline personality disorder;
Treatment of Depression Collaborative Research Program;
Cognitive variable (Lam, D.H. (32) 75) Maintenance Therapies for Recurrent Depression Protocol
(Sullivan, P.F. (32) 21)
Childhood; Adolescence; Self rating scale (Ivarsson, T. (32)
115) é Fawcett-Clark Pleasure Capacity Scale
Depression; Anhedonia; Mood induction; Cheese; Visual ana-
Folate; ECT (Wilkinson, A.M. (32) 163) logue scale (Willner, P. (32) 13)
Keyword Index / Journal of Affective Disorders 32 (1994) 293-297
Flow cytometry Hypothalamic-pituitary-thyroid-axis
Bipolar disorder; Immunology; SIL-2R; IL-2; Autoantibody Electroconvulsive therapy; Thyrotropin-releasing hormone;
(Rapaport, M.H. (32) 149) Major depression; Schizophrenia (Hofmann, P. (32) 127)
Fluoxetine Hypothermia
Moclobemide; Atypical depression (Lonnqvist, J. (32) 169) Hydrocortisone; 5-HT,, receptor; Buspirone; REM sleep
(Young, A.H. (32) 139)
Fluvoxamine
Lithium; Long-term treatment; Unipolar (Franchini, L. (32) IL-2
225) Bipolar disorder; Immunology; Flow cytometry; SIL-2R; Au-
toantibody (Rapaport, M.H. (32) 149)
Folate
Depression; ECT (Wilkinson, A.M. (32) 163) Imipramine
Stress; Cognitive therapy; Mood disorder; Depression (Garvey,
M.J. (32) 45)
Follow-up
Delusion; Depression; Psychoprophylaxis (Lykouras, L. (32)
233) Immunology
Bipolar disorder; Flow cytometry; SIL-2R; IL-2; Autoantibody
(Rapaport, M.H. (32) 149)
G,-a
Bipolar disorder; G protein; Linkage analysis; Chromosome
20 (Le, F. (32) 187) Intellectual impairment
Depressive disorder; Melancholia; Neuropsychology (Marcos,
T. (32) 133)
Genetics
Affective disorder; Lithium (Grof, P. (32) 85)
Life event
Mania (Mathew, M.R.K. (32) 157)
G protein
Bipolar disorder; Linkage analysis; G.-a; Chromosome 20 (Le,
F, (32) 187) Lifetime prevalence
Panic disorder; Panic attack; Help-seeking behavior; Early
mental trauma; Harsh discipline (Aoki, Y. (32) 51)
Harsh discipline
Panic disorder; Panic attack; Lifetime prevalence; Help-seek-
ing behavior; Early mental trauma (Aoki, Y. (32) 51) Linkage analysis
Bipolar disorder; G protein; G.-a; Chromosome 20 (Le, F.
(32) 187)
Heart rate analysis
Heart rate variability; Melancholic depression; Panic disorder;
Reactive depression (Rechlin, T. (32) 271) Lithium
Affective disorder; Genetics (Grof, P. (32) 85)
Heart rate variability
Heart rate analysis; Melancholic depression; Panic disorder; Fluvoxamine; Long-term treatment; Unipolar (Franchini, L.
Reactive depression (Rechlin, T. (32) 271) (32) 225)
Help-seeking behavior Long-term / short-term
Major depression; Dysthymia (Szadéczky, E. (32) 1)
Panic disorder; Panic attack; Lifetime prevalence; Early men-
tal trauma; Harsh discipline (Aoki, Y. (32) 51)
Long-term treatment
[7H]P aroxetine binding site Fluvoxamine; Lithium; Unipolar (Franchini, L. (32) 225)
Paroxetine; Depression; Platelets; Serotonin; Seasonality
(D’Hondt, P. (32) 27) Maintenance Therapies for Recurrent Depression Protocol
Depression; Treatment; Exclusion-criteria; Borderline person-
5-HT,, receptor ality disorder; Treatment of Depression Collaborative Re-
search Program (Sullivan, P.F. (32) 21)
Hydrocortisone; Buspirone; Hypothermia; REM sleep (Young,
A.H. (32) 139)
Major depression
Dysthymia; Long-term /short-term (Szadéczky, E. (32) 1)
Hydrocortisone
5-HT,, receptor; Buspirone; Hypothermia; REM sleep
(Young, A.H. (32) 139) Brofaromine (Chouinard, G. (32) 105)
296 Keyword Index / Journal of Affective Disorders 32 (1994) 293-297
Electroconvulsive therapy; Thyrotropin-releasing hormone; Neuroendocrine
Schizophrenia; Hypothalamic-pituitary-thyroid-axis (Hof- Obsessive compulsive disorder; L-Tryptophan (Fineberg, N.A.
mann, P. (32) 127) (32) 97)
Cognition; Diurnal rhythm; Cortisol (Moffoot, A.P.R. (32) Neuroleptic
257) Mania; Treatment; Short-term outcome (Licht, R.W. (32) 179)
Mania Neuropsychology
Premorbid personality; Manic type; Melancholic type; Unipo- Depressive disorder; Melancholia; Intellectual impairment
lar depression; Bipolar I/II disorder (Von Zerssen, D. (32) (Marcos, T. (32) 133)
61)
Obsessive compulsive disorder
Life event (Mathew, M.R.K. (32) 157) L-Tryptophan; Neuroendocrine (Fineberg, N.A. (32) 97)
Treatment; Neuroleptic; Short-term outcome (Licht, R.W. Outcome
(32) 179) Chronic depression; Predictor (Schrader, G. (32) 219)
Bipolar disorder; Depressive disorder; Assessment and. diag- Panic attack
nosis (Bauer, M.S. (32) 201) Panic disorder; Lifetime prevalence; Help-seeking behavior;
Early mental trauma; Harsh discipline (Aoki, Y. (32) 51)
Manic type
Premorbid personality; Melancholic type; Unipolar depres- Panic disorder
sion; Bipolar I/II disorder; Mania (Von Zerssen, D. (32) 61) Panic attack; Lifetime prevalence; Help-seeking behavior;
Early mental trauma; Harsh discipline (Aoki, Y. (32) 51)
Melancholia
Depressive disorder; Intellectual impairment; Neuropsychol- Heart rate analysis; Heart rate variability; Melancholic de-
ogy (Marcos, T. (32) 133) pression; Reactive depression (Rechlin, T. (32) 271)
Depression; Somatization; Cross-cultural; Turkish (Ebert, D. Paroxetine
(32) 253) [>H]Paroxetine binding site; Depression; Platelets; Serotonin;
Seasonality (D’Hondt, P. (32) 27)
Melancholic depression
Heart rate analysis; Heart rate variability; Panic disorder; Platelets
Reactive depression (Rechlin, T. (32) 271) Paroxetine; [*H]Paroxetine binding site; Depression; Sero-
tonin; Seasonality (D’Hondt, P. (32) 27)
Melancholic type
Premorbid personality; Manic type; Unipolar depression; Predictor
Bipolar I/II disorder; Mania (Von Zerssen, D. (32) 61) Chronic depression; Outcome (Schrader, G. (32) 219)
Menstrual cycle Premenstrual syndrome
Premenstrual syndrome; Tryptophan depletion; Serotonin; Tryptophan depletion; Serotonin; Symptom aggravation;
Symptom aggravation; Tyrosine (Menkes, D.B. (32) 37) Menstrual cycle; Tyrosine (Menkes, D.B. (32) 37)
Moclobemide Premorbid personality
Fluoxetine; Atypical depression (Lonnqvist, J. (32) 169) Manic type; Melancholic type; Unipolar depression; Bipolar
I/II disorder; Mania (Von Zerssen, D. (32) 61)
Monoamine oxidase inhibitor
Selective serotonin reuptake inhibitor; Antidepressant Psychoprophylaxis
(Chouinard, G. (32) 105) Delusion; Depression; Follow-up (Lykouras, L. (32) 233)
Mood disorder Reactive depression
Stress; Cognitive therapy; Imipramine; Depression (Garvey, Heart rate analysis; Heart rate variability; Melancholic de-
M.J. (32) 45) pression; Panic disorder (Rechlin, T. (32) 271)
Mood induction REM sleep
Depression; Anhedonia; Fawcett-Clark Pleasure Capacity Hydrocortisone; 5-HT,, receptor; Buspirone; Hypothermia
Scale; Cheese; Visual analogue scale (Willner, P. (32) 13) (Young, A.H. (32) 139)
Keyword Index / Journal of Affective Disorders 32 (1994) 293-297
Schizophrenia Thyrotropin-releasing hormone
Electroconvulsive therapy; Thyrotropin-releasing hormone; Electroconvulsive therapy; Major depression; Schizophrenia;
Major depression; Hypothalamic-pituitary-thyroid-axis (Hof- Hypothalamic-pituitary-thyroid-axis (Hofmann, P. (32) 127)
mann, P. (32) 127)
Toxicology
Seasonal affective disorder Suicide; Depression; Antidepressant (Isacsson, G. (32) 277)
Cyanocobalamin; Depression (Oren, D.A. (32) 197)
Treatment
Seasonality
Depression; Exclusion-criteria; Borderline personality disor-
Paroxetine; [7H]Paroxetine binding site; Depression; Platelets;
der; Treatment of Depression Collaborative Research Pro-
Serotonin (D’Hondt, P. (32) 27)
gram; Maintenance Therapies for Recurrent Depression Pro-
tocol (Sullivan, P.F. (32) 21)
Selective serotonin reuptake inhibitor
Monoamine oxidase inhibitor; Antidepressant (Chouinard, G.
Mania; Neuroleptic; Short-term outcome (Licht, R.W. (32)
(32) 105)
179)
Self rating scale
Treatment of Depression Collaborative Research Program
Depression; Childhood; Adolescence (Ivarsson, T. (32) 115)
Depression; Treatment; Exclusion-criteria; Borderline person-
ality disorder; Maintenance Therapies for Recurrent Depres-
Serotonin
sion Protocol (Sullivan, P.F. (32) 21)
Paroxetine; [*H]Paroxetine binding site; Depression; Platelets;
Seasonality (D’Hondt, P. (32) 27)
L-Tryptophan
Premenstrual syndrome; Tryptophan depletion; Symptom ag- Obsessive compulsive disorder; Neuroendocrine (Fineberg,
gravation; Menstrual cycle; Tyrosine (Menkes, D.B. (32) 37) N.A. (32) 97)
Short-term outcome Tryptophan depletion
Mania; Treatment; Neuroleptic (Licht, R.W. (32) 179) Premenstrual syndrome; Serotonin; Symptom aggravation;
Menstrual cycle; Tyrosine (Menkes, D.B. (32) 37)
SIL-2R
Bipolar disorder; Immunology; Flow cytometry; IL-2; Auto- Turkish
antibody (Rapaport, M.H. (32) 149) Depression; Somatization; Cross-cultural; Melancholia (Ebert,
D. (32) 253)
Sociotropy
Autonomy; Depression; Anxiety; Attitude; Vulnerability Tyrosine
(Moore, R.G. (32) 239) Premenstrual syndrome; Tryptophan depletion; Serotonin;
Symptom aggravation; Menstrual cycle (Menkes, D.B. (32) 37)
Somatization
Depression; Cross-cultural; Turkish; Melancholia (Ebert, D.
Unipolar
(32) 253)
Fluvoxamine; Lithium; Long-term treatment (Franchini, L.
(32) 225)
Stress
Cognitive therapy; Imipramine; Mood disorder; Depression
Unipolar depression
(Garvey, M.J. (32) 45)
Premorbid personality; Manic type; Melancholic type; Bipolar
I/II disorder; Mania (Von Zerssen, D. (32) 61)
Suicide
Depression; Antidepressant; Toxicology (Isacsson, G. (32) 277)
Visual analogue scale
Depression; Anhedonia; Fawcett-Clark Pleasure Capacity
Symptom aggravation
Scale; Mood induction; Cheese (Willner, P. (32) 13)
Premenstrual syndrome; Tryptophan depletion; Serotonin;
Menstrual cycle; Tyrosine (Menkes, D.B. (32) 37)
Vulnerability
Test-dose model Sociotropy; Autonomy; Depression; Anxiety; Attitude (Moore,
Acute vs. chronic effects; Antidepressive drug; EEG vigilance R.G. (32) 239)
(Ulrich, G. (32) 213)